{"id":49950,"date":"2022-10-23T23:01:41","date_gmt":"2022-10-23T21:01:41","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/greediad-ahf-advocates-hammer-gilead-with-weeklong-protests\/"},"modified":"2022-10-23T23:01:41","modified_gmt":"2022-10-23T21:01:41","slug":"greediad-ahf-advocates-hammer-gilead-with-weeklong-protests","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/greediad-ahf-advocates-hammer-gilead-with-weeklong-protests\/","title":{"rendered":"\u2018Greediad!\u2019 \u2013 AHF Advocates Hammer Gilead with Weeklong Protests"},"content":{"rendered":"<div>\n<p class=\"bwalignc\">\nTwice-daily Protests at Company\u2019s Foster City HQ\u2014Oct. 24-Oct. 28\n<\/p>\n<p class=\"bwalignc\">\n<i>Advocates to protest Gilead\u2019s drug pricing and policies, including illegal restrictions the company placed on access to 340B drug pricing for its branded hepatitis C treatments when covered entities use outside contract pharmacies<\/i>\n<\/p>\n<p>SAN FRANCISCO&#8211;(BUSINESS WIRE)&#8211;Starting Monday, October 24<sup>th<\/sup>, as many as 55 advocates and mobilizers affiliated with <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.aidshealth.org%2F&amp;esheet=52950512&amp;newsitemid=20221021005507&amp;lan=en-US&amp;anchor=AIDS+Healthcare+Foundation&amp;index=1&amp;md5=ccbb534c75ac26477603bf5b1869808e\" rel=\"nofollow noopener\" shape=\"rect\">AIDS Healthcare Foundation<\/a> (AHF), will host a weeklong, twice-daily series of protests targeting drug maker of <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.gilead.com%2F&amp;esheet=52950512&amp;newsitemid=20221021005507&amp;lan=en-US&amp;anchor=Gilead+Sciences&amp;index=2&amp;md5=dede1d0f5040543185ece392c658d0fd\" rel=\"nofollow noopener\" shape=\"rect\">Gilead Sciences<\/a> over the Bay Area company\u2019s drug pricing and policies. The protesters, who have repurposed Gilead\u2019s logo as \u201cGreediad,\u201d will start protesting each day at 8:30 a.m. and resume again at 12:00 noon PT in front of the headquarters of <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.gilead.com%2F&amp;esheet=52950512&amp;newsitemid=20221021005507&amp;lan=en-US&amp;anchor=Gilead+Sciences&amp;index=3&amp;md5=5b520d016f1ac183f752a61534dbcdc7\" rel=\"nofollow noopener\" shape=\"rect\">Gilead Sciences<\/a> (333 Lakeside Dr., Foster City, CA 94404).\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20221021005507\/en\/1610773\/5\/ADV_GREEDIAD-Poster-24-x-18_MARCH22_Stop-Greediad.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20221021005507\/en\/1610773\/21\/ADV_GREEDIAD-Poster-24-x-18_MARCH22_Stop-Greediad.jpg\"><\/a><\/p>\n<p>\nA larger theatrical protest with costumes\u2014a $1 million dollar bill, pigs\u2019 heads and snouts, advocates dressed as burglars with money bags slung over their shoulders\u2014will take place on Wednesday, October 26 at 12:00 noon PT.\n<\/p>\n<table cellspacing=\"0\" class=\"bwtablemarginb bwblockalignl\">\n<tr>\n<td class=\"bwvertalignt bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\nWHAT:\n<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\u00a0<\/td>\n<td class=\"bwvertalignt bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\nGilead\u2014&#8221;Greediad!\u201d\u2014Drug Company Protest\n<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwvertalignt bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\n\u00a0\n<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\u00a0<\/td>\n<td class=\"bwvertalignt bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwvertalignt bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\nWHEN:\n<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\u00a0<\/td>\n<td class=\"bwvertalignt bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\n<b><span class=\"bwuline\">DAILY protests 8:30 a.m. and again at 12:00 noon<\/span><\/b>\n<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwvertalignt bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\n\u00a0\n<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\u00a0<\/td>\n<td class=\"bwvertalignt bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\n<i>Mon., Oct. 24 8:30 a.m. &amp; again at 12:00 noon<\/i>\n<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwvertalignt bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\n\u00a0\n<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\u00a0<\/td>\n<td class=\"bwvertalignt bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\n<i>Tues., Oct. 25 8:30 a.m. &amp; again at 12:00 noon<\/i>\n<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwvertalignt bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\n\u00a0\n<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\u00a0<\/td>\n<td class=\"bwvertalignt bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\n<i>Weds., Oct. 26 8:30 a.m. &amp; again at 12:00 noon<\/i>\n<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwvertalignt bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\nNOTE:\n<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\u00a0<\/td>\n<td class=\"bwvertalignt bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\nWednesday\u2019s PROTEST will be a larger, more theatrical protest with advocates dressed in costumes\n<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwvertalignt bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\n\u00a0\n<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\u00a0<\/td>\n<td class=\"bwvertalignt bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\n<i>Thurs., Oct. 27 8:30 a.m. &amp; again at 12:00 noon<\/i>\n<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwvertalignt bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\n\u00a0\n<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\u00a0<\/td>\n<td class=\"bwvertalignt bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\n<i>Fri., Oct. 28 8:30 a.m. &amp; again at 12:00 noon<\/i>\n<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwvertalignt bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\n\u00a0\n<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\u00a0<\/td>\n<td class=\"bwvertalignt bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwvertalignt bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\nWHERE:\n<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\u00a0<\/td>\n<td class=\"bwvertalignt bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\n<i>In front of<\/i>:\n<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwvertalignt bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\n\u00a0\n<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\u00a0<\/td>\n<td class=\"bwvertalignt bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\n<b>Gilead Sciences, Inc.<\/b> Headquarters\n<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwvertalignt bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\n\u00a0\n<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\u00a0<\/td>\n<td class=\"bwvertalignt bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\n333 Lakeside Dr., Foster City, CA 94404\n<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwpadl0\" colspan=\"1\" rowspan=\"1\"><\/td>\n<td class=\"bwpadl0\" colspan=\"1\" rowspan=\"1\"><\/td>\n<td class=\"bwpadl0\" colspan=\"1\" rowspan=\"1\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td class=\"bwvertalignt bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\nWHO:\n<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\u00a0<\/td>\n<td class=\"bwvertalignt bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\n35-50 advocates &amp; protesters with \u201cGreediad\u201d and other banners and signs\n<\/p>\n<\/td>\n<\/tr>\n<\/table>\n<p>\nAdvocates will protest Gilead\u2019s over its drug pricing and policies, including illegal restrictions the company placed on access to 340B drug pricing earlier this year for its branded hepatitis C treatments when covered entities use outside contract pharmacies.\n<\/p>\n<p>\nAccording to a <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2F340breport.com%2Fgilead-announces-340b-contract-pharmacy-restrictions-that-apply-to-hospital-and-grantee-entities%2F&amp;esheet=52950512&amp;newsitemid=20221021005507&amp;lan=en-US&amp;anchor=340B+Report+article&amp;index=4&amp;md5=5d3df2d6665317805bfffd631add3e92\" rel=\"nofollow noopener\" shape=\"rect\">340B Report article<\/a> from March, Gilead became the 15th drug manufacturer to place unlawful restrictions on 340B contract pharmacy programs. Lawyers for the Health and Human Services Department (HHS) in both the Biden and Trump administrations have said these restrictions are clearly illegal, yet drug companies like Gilead forge ahead with the lawbreaking in search of even greater profits.\n<\/p>\n<p>\nMoreover, according to the 340B Report, Gilead is now refusing to offer the 340B discount price for HIV drugs to providers who use contract pharmacies. Earlier this year, Gilead suddenly, dramatically increased the price that safety net providers pay for Descovy \u2013 a drug needed for both HIV treatment and HIV prevention.\n<\/p>\n<p>\nThe <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.hrsa.gov%2Fopa%2Findex.html&amp;esheet=52950512&amp;newsitemid=20221021005507&amp;lan=en-US&amp;anchor=340B+drug+pricing+program&amp;index=5&amp;md5=5016613deee10385957227404d938a50\" rel=\"nofollow noopener\" shape=\"rect\">340B drug pricing program<\/a> is administered by the U.S. Health Resources &amp; Services Administration (HRSA). It has helped provide low-cost medications and better health outcomes for millions of Americans and the nonprofit clinics and hospitals that serve them. Safety net providers like Ryan White providers who serve patients living with HIV have the right under the 340B statute to purchase drugs for their patients at a discounted price. In March, Gilead put profits before patients by unilaterally imposing unlawful conditions on when and how it will give discounts for certain Hepatitis C drugs.\n<\/p>\n<p>\n\u201cWe are fighting against Gilead\u2019s greed to fatten their corporate pockets. Their money-making schemes not only impact community partners and providers but also patients, like myself. I am one of many voices of community advocates who stand against pharma greed. Gilead cares more about money than lives,\u201d said <b>Jesse Brooks<\/b>, AIDS advocate and AHF mobilizer.\n<\/p>\n<p>\nIn response to Gilead\u2019s (and others\u2019) illegal restrictions on 340B access for higher profits, AHF also earlier this year asked Congress and the FDA to conduct a formal investigation of Gilead as well as increase scrutiny of the actions of pharmaceutical companies.\n<\/p>\n<p>\nIn conjunction with the week of Gilead protests October 24 through October 28, AHF will also run a series of Gilead\/Greediad ads in several Bay Area print and online publications. The Greediad advertisements will note that:\n<\/p>\n<ul class=\"bwlistdisc\">\n<li>\n<i>Gilead Sciences has made tens of billions of dollars from drug price gouging.<\/i>\n<\/li>\n<li>\n<i>Gilead is infamous for charging $1000 for a single pill of the Hep C drug Sovaldi.<\/i>\n<\/li>\n<li>\n<i>Gilead is being sued by thousands of HIV patients for knowingly selling an inferior drug until its patent ran out.<\/i>\n<\/li>\n<li>\n<i>Gilead replaced the inferior drug with Biktarvy and has now slashed their patient assistance program.<\/i>\n<\/li>\n<li>\n<i>Gilead has doubled the price they charge to safety net providers of their HIV prevention drug Descovy.<\/i>\n<\/li>\n<li>\n<i>Gilead&#8217;s greed has no limit making them the poster child for drug company profiteering.<\/i>\n<\/li>\n<\/ul>\n<p>\nAHF mobilizers will be also deploying social media in real time at many of these Gilead protests and will be using hashtags: #BadGilead &#8211; #PeopleBeforeProfit &#8211; #GreedyGilead\n<\/p>\n<p>\n<b>AIDS Healthcare Foundation<\/b> (AHF), the largest global AIDS organization, currently provides medical care and\/or services to over 1.6 million individuals in 45 countries worldwide in the US, Africa, Latin America\/Caribbean, the Asia\/Pacific Region and Eastern Europe. To learn more about AHF, please visit our website: <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.aidshealth.org%2F&amp;esheet=52950512&amp;newsitemid=20221021005507&amp;lan=en-US&amp;anchor=www.aidshealth.org&amp;index=6&amp;md5=f71551a9e9253e1b7f0dd05dc896f0c1\" rel=\"nofollow noopener\" shape=\"rect\">www.aidshealth.org<\/a>, find us on Facebook: <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.facebook.com%2Faidshealth&amp;esheet=52950512&amp;newsitemid=20221021005507&amp;lan=en-US&amp;anchor=www.facebook.com%2Faidshealth&amp;index=7&amp;md5=5e0ab6747577854367ea2f78500c961d\" rel=\"nofollow noopener\" shape=\"rect\">www.facebook.com\/aidshealth<\/a> and follow us on Twitter: <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Ftwitter.com%2Faidshealthcare&amp;esheet=52950512&amp;newsitemid=20221021005507&amp;lan=en-US&amp;anchor=%40aidshealthcare&amp;index=8&amp;md5=a1c548a595b7efbb9de8d05a6664b45b\" rel=\"nofollow noopener\" shape=\"rect\">@aidshealthcare<\/a> and Instagram: <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Finstagram.com%2Faidshealthcare&amp;esheet=52950512&amp;newsitemid=20221021005507&amp;lan=en-US&amp;anchor=%40aidshealthcare&amp;index=9&amp;md5=747ff201a051b5da09cdb5dfa0ee3312\" rel=\"nofollow noopener\" shape=\"rect\">@aidshealthcare<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b>Eduardo Martinez<\/b>, AHF Advocacy Manager, 323.535.8511 mobile <a target=\"_blank\" href=\"&#109;&#x61;i&#108;&#x74;&#111;&#x3a;E&#100;&#x75;a&#x72;&#x64;&#111;&#x2e;m&#97;&#x72;t&#x69;&#x6e;&#101;&#x7a;&#64;&#97;&#x68;&#102;&#x2e;o&#114;&#x67;\" rel=\"nofollow noopener\" shape=\"rect\">&#69;&#x64;&#117;&#x61;r&#x64;o&#46;&#x6d;&#97;&#x72;&#116;&#x69;n&#x65;z&#64;&#x61;&#104;&#x66;&#46;&#x6f;r&#x67;<\/a><br \/><b>Jesse Brooks, <\/b>AHF Bay Area Advocacy Mobilizer, +1.510.575.8245 mobile <a target=\"_blank\" href=\"m&#97;&#105;&#x6c;&#x74;&#x6f;&#x3a;j&#101;&#115;&#115;&#x65;&#x2e;&#x62;ro&#111;&#107;&#x73;&#x40;&#x61;hf&#46;&#111;&#x72;&#x67;\" rel=\"nofollow noopener\" shape=\"rect\">&#x6a;&#x65;&#115;&#115;e&#46;&#x62;&#x72;&#x6f;&#111;ks&#x40;&#x61;&#x68;&#102;&#46;o&#x72;&#x67;<\/a><br \/><b>Tonya Thurman, <\/b>MHA, Associate Director of Mobilization Campaigns for AHF +1.216.288.5945 mobile <a target=\"_blank\" href=\"&#x6d;a&#x69;&#108;&#x74;&#111;:&#x6c;a&#x74;&#111;&#x6e;&#121;a&#x2e;&#116;&#x68;&#117;r&#x6d;a&#x6e;&#64;&#x61;&#104;f&#x2e;o&#x72;&#103;\" rel=\"nofollow noopener\" shape=\"rect\">&#x6c;&#97;t&#x6f;&#x6e;&#121;a&#x2e;&#x74;&#104;u&#x72;&#x6d;&#97;n&#x40;&#x61;&#104;f&#x2e;&#111;&#114;g<\/a><br \/>(Weds., Oct. 26) <b>Lauren Hogan<\/b>, AHF Associate Director, Communications +1.310.940.0802 <a target=\"_blank\" href=\"m&#97;&#x69;&#x6c;&#x74;o&#58;&#x6c;&#x61;&#x75;r&#101;&#x6e;&#x2e;&#x68;o&#103;&#x61;&#x6e;&#x40;a&#104;&#x66;&#x2e;&#x6f;r&#103;\" rel=\"nofollow noopener\" shape=\"rect\">lauren&#46;&#104;&#111;&#103;&#97;&#110;&#64;&#x61;&#x68;&#x66;&#x2e;&#x6f;&#x72;&#x67;<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Twice-daily Protests at Company\u2019s Foster City HQ\u2014Oct. 24-Oct. 28 Advocates to protest Gilead\u2019s drug pricing and policies, including illegal restrictions the company placed on access to 340B drug pricing for its branded hepatitis C treatments when covered entities use outside contract pharmacies SAN FRANCISCO&#8211;(BUSINESS WIRE)&#8211;Starting Monday, October 24th, as many as 55 advocates and mobilizers &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/greediad-ahf-advocates-hammer-gilead-with-weeklong-protests\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-49950","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>\u2018Greediad!\u2019 \u2013 AHF Advocates Hammer Gilead with Weeklong Protests - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/greediad-ahf-advocates-hammer-gilead-with-weeklong-protests\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\u2018Greediad!\u2019 \u2013 AHF Advocates Hammer Gilead with Weeklong Protests - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Twice-daily Protests at Company\u2019s Foster City HQ\u2014Oct. 24-Oct. 28 Advocates to protest Gilead\u2019s drug pricing and policies, including illegal restrictions the company placed on access to 340B drug pricing for its branded hepatitis C treatments when covered entities use outside contract pharmacies SAN FRANCISCO&#8211;(BUSINESS WIRE)&#8211;Starting Monday, October 24th, as many as 55 advocates and mobilizers ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/greediad-ahf-advocates-hammer-gilead-with-weeklong-protests\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-23T21:01:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221021005507\/en\/1610773\/21\/ADV_GREEDIAD-Poster-24-x-18_MARCH22_Stop-Greediad.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/greediad-ahf-advocates-hammer-gilead-with-weeklong-protests\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/greediad-ahf-advocates-hammer-gilead-with-weeklong-protests\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"\u2018Greediad!\u2019 \u2013 AHF Advocates Hammer Gilead with Weeklong Protests\",\"datePublished\":\"2022-10-23T21:01:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/greediad-ahf-advocates-hammer-gilead-with-weeklong-protests\\\/\"},\"wordCount\":882,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/greediad-ahf-advocates-hammer-gilead-with-weeklong-protests\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221021005507\\\/en\\\/1610773\\\/21\\\/ADV_GREEDIAD-Poster-24-x-18_MARCH22_Stop-Greediad.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/greediad-ahf-advocates-hammer-gilead-with-weeklong-protests\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/greediad-ahf-advocates-hammer-gilead-with-weeklong-protests\\\/\",\"name\":\"\u2018Greediad!\u2019 \u2013 AHF Advocates Hammer Gilead with Weeklong Protests - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/greediad-ahf-advocates-hammer-gilead-with-weeklong-protests\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/greediad-ahf-advocates-hammer-gilead-with-weeklong-protests\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221021005507\\\/en\\\/1610773\\\/21\\\/ADV_GREEDIAD-Poster-24-x-18_MARCH22_Stop-Greediad.jpg\",\"datePublished\":\"2022-10-23T21:01:41+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/greediad-ahf-advocates-hammer-gilead-with-weeklong-protests\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/greediad-ahf-advocates-hammer-gilead-with-weeklong-protests\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/greediad-ahf-advocates-hammer-gilead-with-weeklong-protests\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221021005507\\\/en\\\/1610773\\\/21\\\/ADV_GREEDIAD-Poster-24-x-18_MARCH22_Stop-Greediad.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221021005507\\\/en\\\/1610773\\\/21\\\/ADV_GREEDIAD-Poster-24-x-18_MARCH22_Stop-Greediad.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/greediad-ahf-advocates-hammer-gilead-with-weeklong-protests\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\u2018Greediad!\u2019 \u2013 AHF Advocates Hammer Gilead with Weeklong Protests\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u2018Greediad!\u2019 \u2013 AHF Advocates Hammer Gilead with Weeklong Protests - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/greediad-ahf-advocates-hammer-gilead-with-weeklong-protests\/","og_locale":"en_US","og_type":"article","og_title":"\u2018Greediad!\u2019 \u2013 AHF Advocates Hammer Gilead with Weeklong Protests - Pharma Trend","og_description":"Twice-daily Protests at Company\u2019s Foster City HQ\u2014Oct. 24-Oct. 28 Advocates to protest Gilead\u2019s drug pricing and policies, including illegal restrictions the company placed on access to 340B drug pricing for its branded hepatitis C treatments when covered entities use outside contract pharmacies SAN FRANCISCO&#8211;(BUSINESS WIRE)&#8211;Starting Monday, October 24th, as many as 55 advocates and mobilizers ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/greediad-ahf-advocates-hammer-gilead-with-weeklong-protests\/","og_site_name":"Pharma Trend","article_published_time":"2022-10-23T21:01:41+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221021005507\/en\/1610773\/21\/ADV_GREEDIAD-Poster-24-x-18_MARCH22_Stop-Greediad.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/greediad-ahf-advocates-hammer-gilead-with-weeklong-protests\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/greediad-ahf-advocates-hammer-gilead-with-weeklong-protests\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"\u2018Greediad!\u2019 \u2013 AHF Advocates Hammer Gilead with Weeklong Protests","datePublished":"2022-10-23T21:01:41+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/greediad-ahf-advocates-hammer-gilead-with-weeklong-protests\/"},"wordCount":882,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/greediad-ahf-advocates-hammer-gilead-with-weeklong-protests\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221021005507\/en\/1610773\/21\/ADV_GREEDIAD-Poster-24-x-18_MARCH22_Stop-Greediad.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/greediad-ahf-advocates-hammer-gilead-with-weeklong-protests\/","url":"https:\/\/pharma-trend.com\/en\/greediad-ahf-advocates-hammer-gilead-with-weeklong-protests\/","name":"\u2018Greediad!\u2019 \u2013 AHF Advocates Hammer Gilead with Weeklong Protests - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/greediad-ahf-advocates-hammer-gilead-with-weeklong-protests\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/greediad-ahf-advocates-hammer-gilead-with-weeklong-protests\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221021005507\/en\/1610773\/21\/ADV_GREEDIAD-Poster-24-x-18_MARCH22_Stop-Greediad.jpg","datePublished":"2022-10-23T21:01:41+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/greediad-ahf-advocates-hammer-gilead-with-weeklong-protests\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/greediad-ahf-advocates-hammer-gilead-with-weeklong-protests\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/greediad-ahf-advocates-hammer-gilead-with-weeklong-protests\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221021005507\/en\/1610773\/21\/ADV_GREEDIAD-Poster-24-x-18_MARCH22_Stop-Greediad.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221021005507\/en\/1610773\/21\/ADV_GREEDIAD-Poster-24-x-18_MARCH22_Stop-Greediad.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/greediad-ahf-advocates-hammer-gilead-with-weeklong-protests\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"\u2018Greediad!\u2019 \u2013 AHF Advocates Hammer Gilead with Weeklong Protests"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49950","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=49950"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49950\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=49950"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=49950"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=49950"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}